Turnstone Biologics Corp. (TSBX)
Aug 11, 2025 - TSBX was delisted (reason: acquired by XOMA)
0.3550
0.00 (0.00%)
Inactive · Last trade price on Aug 8, 2025

Turnstone Biologics Stock Forecast

TSBX's stock price has decreased by -83.6% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 3 analysts with 12-month price forecasts for Turnstone Biologics stock had an average target of 4.75, with a low estimate of 0.50 and a high estimate of 10.

Price Target: $4.75 (+1,238.03%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$0.50$4.75$3.75$10
Change+40.85%+1238.0%+956.34%+2716.9%
* Price targets were last updated on Oct 14, 2024.

Analyst Ratings

The average analyst rating for Turnstone Biologics stock from 3 stock analysts was "Buy". This means that analysts believed this stock was likely to outperform the market over the next twelve months.

Recommendation Trends

RatingMar '25Apr '25May '25Jun '25Jul '25Aug '25
Strong Buy111111
Buy111111
Hold111111
Sell000000
Strong Sell000000
Total333333

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
B of A Securities
B of A Securities
Hold
Downgrades
$10$0.5
HoldDowngrades$10$0.5+40.85%Oct 14, 2024
B of A Securities
B of A Securities
Strong Buy
Maintains
$12$10
Strong BuyMaintains$12$10+2,716.90%Aug 19, 2024
Piper Sandler
Piper Sandler
Buy
Maintains
$20$3.75
BuyMaintains$20$3.75+956.34%Aug 19, 2024
B of A Securities
B of A Securities
Strong Buy
Initiates
$18
Strong BuyInitiates$18+4,970.42%Aug 15, 2023
Piper Sandler
Piper Sandler
Buy
Initiates
$20
BuyInitiates$20+5,533.80%Aug 15, 2023
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.70
from -3.07
EPS Next Year
-0.52
from -0.70
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
101.29M73.30M19.31M----
Revenue Growth
--27.64%-73.66%----
EPS
1.28-12.49-4.78-3.07-0.70-0.52-
EPS Growth
-------
Forward PE
-------
No. Analysts
----334
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
Highn/an/a
Avgn/an/a
Lown/an/a

Revenue Growth

Revenue Growth20252026202720282029
High--
Avg--
Low--

EPS Forecast

EPS20252026
High-0.72-0.54
Avg-0.70-0.52
Low-0.68-0.50

EPS Growth

EPS Growth20252026
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.